Merck KGaA

General ticker "MKGAF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $59.5B (TTM average)

Merck KGaA follows the US Stock Market performance with the rate: 26.9%.

Estimated limits based on current volatility of 2.8%: low 121.72$, high 128.85$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-04-29, amount 2.50$ (Y2.02%)
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [109.38$, 163.87$]
  • 2026-12-31 to 2027-12-31 estimated range: [111.46$, 166.83$]

Similar symbols

Short-term MKGAF quotes

Long-term MKGAF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €20,993.00MM €21,156.00MM €21,094.10MM
Operating Expenses €17,384.00MM €17,511.00MM €17,030.62MM
Operating Income €3,609.00MM €3,645.00MM €4,063.48MM
Non-Operating Income €-125.00MM €-109.00MM €-756.72MM
Interest Expense €272.00MM €292.00MM €261.90MM
R&D Expense €2,445.00MM €2,279.00MM €2,381.11MM
Income(Loss) €3,484.00MM €3,536.00MM €3,306.76MM
Taxes €650.00MM €751.00MM €692.74MM
Profit(Loss)* €2,824.00MM €2,777.00MM €2,607.02MM
Stockholders Equity €26,680.00MM €29,912.00MM €28,581.29MM
Inventory €4,637.00MM €4,484.00MM €4,560.29MM
Assets €48,495.00MM €51,567.00MM €52,080.49MM
Operating Cash Flow €3,784.00MM €4,586.00MM €3,930.53MM
Capital expenditure €2,023.00MM €2,184.00MM €1,583.41MM
Investing Cash Flow €-1,892.00MM €-3,050.00MM €-4,259.40MM
Financing Cash Flow €-1,732.00MM €-985.00MM €627.76MM
Earnings Per Share** €6.49 €6.39 €6.00

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.